lansoprazole and trolamine salicylate

lansoprazole has been researched along with trolamine salicylate in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Curran, MP; Wellington, K	1
Chiou, CF; Ofman, JJ; Spiegel, BM	1
Asaka, M; Ashida, K; Hiraishi, H; Hiramatsu, N; Kanto, T; Katsuo, S; Kontani, T; Matsui, S; Mizokami, Y; Sakaki, N; Soen, S; Sugano, K; Takei, Y; Takeuchi, T	1

Reviews

2 review(s) available for lansoprazole and trolamine salicylate

Article	Year
Delayed-release lansoprazole plus naproxen. Drugs, 2004, Volume: 64, Issue:17 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis; Clinical Trials as Topic; Delayed-Action Preparations; Drug Combinations; Humans; Lansoprazole; Naproxen; Omeprazole; Ulcer	2004
Minimizing complications from nonsteroidal antiinflammatory drugs: cost-effectiveness of competing strategies in varying risk groups. Arthritis and rheumatism, 2005, Apr-15, Volume: 53, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Aspirin; Celecoxib; Cost-Benefit Analysis; Drug Therapy, Combination; Gastrointestinal Diseases; Humans; Lactones; Lansoprazole; Naproxen; Omeprazole; Proton Pump Inhibitors; Pyrazoles; Rheumatology; Sulfonamides; Sulfones	2005

Article

Year

Delayed-release lansoprazole plus naproxen.

Drugs, 2004, Volume: 64, Issue:17

Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis; Clinical Trials as Topic; Delayed-Action Preparations; Drug Combinations; Humans; Lansoprazole; Naproxen; Omeprazole; Ulcer

2004

Minimizing complications from nonsteroidal antiinflammatory drugs: cost-effectiveness of competing strategies in varying risk groups.

Arthritis and rheumatism, 2005, Apr-15, Volume: 53, Issue:2

Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Aspirin; Celecoxib; Cost-Benefit Analysis; Drug Therapy, Combination; Gastrointestinal Diseases; Humans; Lactones; Lansoprazole; Naproxen; Omeprazole; Proton Pump Inhibitors; Pyrazoles; Rheumatology; Sulfonamides; Sulfones

2005

Trials

1 trial(s) available for lansoprazole and trolamine salicylate

Article	Year
Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial. Journal of gastroenterology, 2012, Volume: 47, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis; Double-Blind Method; Duodenal Ulcer; Female; Gefarnate; Humans; Kaplan-Meier Estimate; Lansoprazole; Low Back Pain; Male; Middle Aged; Prospective Studies; Secondary Prevention; Stomach Ulcer; Treatment Outcome	2012

Article

Year

Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial.

Journal of gastroenterology, 2012, Volume: 47, Issue:5

Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis; Double-Blind Method; Duodenal Ulcer; Female; Gefarnate; Humans; Kaplan-Meier Estimate; Lansoprazole; Low Back Pain; Male; Middle Aged; Prospective Studies; Secondary Prevention; Stomach Ulcer; Treatment Outcome

2012